MaxLinear [MXL] vs Alpha & Omega [AOSL] Detailed Stock Comparison
MaxLinear
NASDAQ
Loading...
Alpha & Omega
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: MaxLinear wins in 7 metrics, Alpha & Omega wins in 11 metrics, with 0 ties. Alpha & Omega appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | MaxLinear | Alpha & Omega | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 24.44 | 57.17 | MaxLinear |
| Price-to-Book Ratio | 2.91 | 0.94 | Alpha & Omega |
| Debt-to-Equity Ratio | 30.24 | 39.04 | MaxLinear |
| PEG Ratio | 45.44 | 35.97 | Alpha & Omega |
| EV/EBITDA | -16.67 | 23.30 | MaxLinear |
| Profit Margin (TTM) | -55.53% | -3.33% | Alpha & Omega |
| Operating Margin (TTM) | -17.49% | 12.61% | Alpha & Omega |
| EBITDA Margin (TTM) | N/A | 12.61% | N/A |
| Return on Equity | -37.97% | -2.55% | Alpha & Omega |
| Return on Assets (TTM) | -9.12% | -1.01% | Alpha & Omega |
| Free Cash Flow (TTM) | $-68.74M | $-11.38M | Alpha & Omega |
| 1-Year Return | 38.81% | -21.26% | MaxLinear |
| Price-to-Sales Ratio (TTM) | 3.77 | 1.23 | Alpha & Omega |
| Enterprise Value | $1.46B | $977.33M | MaxLinear |
| EV/Revenue Ratio | 3.87 | 1.44 | Alpha & Omega |
| Gross Profit Margin (TTM) | 56.54% | 21.37% | MaxLinear |
| Revenue per Share (TTM) | $4 | $23 | Alpha & Omega |
| Earnings per Share (Diluted) | $-2.47 | $-0.79 | Alpha & Omega |
| Beta (Stock Volatility) | 1.72 | 2.11 | MaxLinear |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
MaxLinear vs Alpha & Omega Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| MaxLinear | 3.41% | 12.11% | 21.82% | 72.24% | -20.56% | -11.55% |
| Alpha & Omega | -2.32% | -3.01% | 6.82% | 43.51% | -23.07% | -24.99% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| MaxLinear | 38.81% | -59.08% | -33.78% | 55.67% | 57.36% | -7.04% |
| Alpha & Omega | -21.26% | -35.69% | 137.32% | 267.43% | 110.36% | 53.04% |
Performance & Financial Health Analysis: MaxLinear vs Alpha & Omega
| Metric | MXL | AOSL |
|---|---|---|
| Market Information | ||
| Market Cap | $1.42B | $835.07M |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 2,438,730 | 196,184 |
| 90 Day Avg. Volume | 1,411,853 | 247,255 |
| Last Close | $17.31 | $27.41 |
| 52 Week Range | $8.35 - $25.73 | $15.90 - $53.29 |
| % from 52W High | -32.72% | -48.56% |
| All-Time High | $77.89 (Dec 27, 2021) | $69.99 (Mar 28, 2022) |
| % from All-Time High | -77.78% | -60.84% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.18% | 0.45% |
| Quarterly Earnings Growth | 0.18% | 0.10% |
| Financial Health | ||
| Profit Margin (TTM) | -0.56% | -0.03% |
| Operating Margin (TTM) | -0.17% | 0.13% |
| Return on Equity (TTM) | -0.38% | -0.03% |
| Debt to Equity (MRQ) | 30.24 | 39.04 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $5.62 | $29.79 |
| Cash per Share (MRQ) | $1.25 | $6.80 |
| Operating Cash Flow (TTM) | $-59,480,000 | $39.61M |
| Levered Free Cash Flow (TTM) | $21.21M | $30.61M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: MaxLinear vs Alpha & Omega
| Metric | MXL | AOSL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 24.44 | 57.17 |
| Forward P/E | 45.44 | 35.97 |
| PEG Ratio | 45.44 | 35.97 |
| Price to Sales (TTM) | 3.77 | 1.23 |
| Price to Book (MRQ) | 2.91 | 0.94 |
| Market Capitalization | ||
| Market Capitalization | $1.42B | $835.07M |
| Enterprise Value | $1.46B | $977.33M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.87 | 1.44 |
| Enterprise to EBITDA | -16.67 | 23.30 |
| Risk & Other Metrics | ||
| Beta | 1.72 | 2.11 |
| Book Value per Share (MRQ) | $5.62 | $29.79 |
Financial Statements Comparison: MaxLinear vs Alpha & Omega
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | MXL | AOSL |
|---|---|---|
| Revenue/Sales | $95.93M | $164.64M |
| Cost of Goods Sold | $42.10M | $129.46M |
| Gross Profit | $53.83M | $35.18M |
| Research & Development | $55.46M | $23.40M |
| Operating Income (EBIT) | $-38.22M | $-10.66M |
| EBITDA | $-27.47M | $8.97M |
| Pre-Tax Income | $-49.00M | $-9.89M |
| Income Tax | $711,000 | $660,000 |
| Net Income (Profit) | $-49.71M | $-10.81M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | MXL | AOSL |
|---|---|---|
| Cash & Equivalents | $102.77M | $169.36M |
| Total Current Assets | $320.41M | $399.39M |
| Total Current Liabilities | $196.89M | $155.42M |
| Long-Term Debt | $138.92M | $37.07M |
| Total Shareholders Equity | $493.18M | $886.29M |
| Retained Earnings | $-413.44M | $610.99M |
| Property, Plant & Equipment | $81.84M | $58.50M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | MXL | AOSL |
|---|---|---|
| Operating Cash Flow | $-23.41M | $18.78M |
| Capital Expenditures | $-1.99M | $-8.43M |
| Free Cash Flow | $-13.39M | $-1.06M |
| Debt Repayment | N/A | $-3.16M |
| Common Stock Repurchase | $-10,000 | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | MXL | AOSL |
|---|---|---|
| Shares Short | 5.57M | 1.33M |
| Short Ratio | 5.99 | 5.06 |
| Short % of Float | 0.10% | 0.06% |
| Average Daily Volume (10 Day) | 2,438,730 | 196,184 |
| Average Daily Volume (90 Day) | 1,411,853 | 247,255 |
| Shares Outstanding | 84.61M | 28.97M |
| Float Shares | 80.98M | 24.77M |
| % Held by Insiders | 0.07% | 0.17% |
| % Held by Institutions | 0.83% | 0.78% |
Dividend Analysis & Yield Comparison: MaxLinear vs Alpha & Omega
| Metric | MXL | AOSL |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |